Variability in functional p53 reactivation by PRIMA-1Met/APR-246 in Ewing sarcoma

被引：0
|
作者：
D N T Aryee
S Niedan
J Ban
R Schwentner
K Muehlbacher
M Kauer
R Kofler
H Kovar
机构：
[1] Children’s Cancer Research Institute (CCRI),Department of Pediatrics
[2] Medical University,Division of Molecular Pathophysiology
[3] Biocenter,undefined
[4] Medical University Innsbruck,undefined
来源：
British Journal of Cancer | 2013年 / 109卷
关键词：
PRIMA-1; /APR-246; Ewing sarcoma; apoptosis; p53;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2696 / 2704
页数：8
相关论文
共 50 条
  • [21] Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis
    J M R Lambert
    A Moshfegh
    P Hainaut
    K G Wiman
    V J N Bykov
    Oncogene, 2010, 29 : 1329 - 1338
  • [22] APR-246 increases tumor antigenicity independent of p53
    Michels, Judith
    Venkatesh, Divya
    Liu, Cailian
    Budhu, Sadna
    Zhong, Hong
    George, Mariam M.
    Thach, Daniel
    Yao, Zhong-Ke
    Ouerfelli, Ouathek
    Liu, Hengrui
    Stockwell, Brent R.
    Campesato, Luis Felipe
    Zamarin, Dmitriy
    Zappasodi, Roberta
    Wolchok, Jedd D.
    Merghoub, Taha
    LIFE SCIENCE ALLIANCE, 2024, 7 (01)
  • [23] Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis
    Lambert, J. M. R.
    Moshfegh, A.
    Hainaut, P.
    Wiman, K. G.
    Bykov, V. J. N.
    ONCOGENE, 2010, 29 (09) : 1329 - 1338
  • [24] Antitumor Effects of PRIMA-1 and PRIMA-1Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?
    Menichini, Paola
    Monti, Paola
    Speciale, Andrea
    Cutrona, Giovanna
    Matis, Serena
    Fais, Franco
    Taiana, Elisa
    Neri, Antonino
    Bomben, Riccardo
    Gentile, Massimo
    Gattei, Valter
    Ferrarini, Manlio
    Morabito, Fortunato
    Fronza, Gilberto
    CELLS, 2021, 10 (01) : 1 - 15
  • [25] Impaired epithelial differentiation of induced pluripotent stem cells from EEC patients is rescued by APR-246/PRIMA-1MET
    Aberdam, Daniel
    Aberdam, Edith
    Petit, Isabelle
    Shalom-Feuerstein, Ruby
    HUMAN GENE THERAPY, 2013, 24 (05) : A27 - A27
  • [26] APR-246/PRIMA-1MET rescues epidermal differentiation in skin keratinocytes derived from EEC syndrome patients with p63 mutations
    Shen, Jinfeng
    van den Bogaard, Ellen H.
    Kouwenhoven, Evelyn N.
    Bykov, Vladimir J. N.
    Rinne, Tuula
    Zhang, Qiang
    Tjabringa, Geuranne S.
    Gilissen, Christian
    van Heeringen, Simon J.
    Schalkwijk, Joost
    van Bokhoven, Hans
    Wiman, Klas G.
    Zhou, Huiqing
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (06) : 2157 - 2162
  • [27] PRIMA-1Met/APR-246 induces wild-type p53-dependent suppression of malignant melanoma tumor growth in 3D culture and in vivo
    Bao, Wenjie
    Chen, Ming
    Zhao, Xu
    Kumar, Rajiv
    Spinnler, Clemens
    Thullberg, Minna
    Issaeva, Natalia
    Selivanova, Galina
    Stromblad, Staffan
    CELL CYCLE, 2011, 10 (02) : 301 - 307
  • [28] Synergistic effects of PRIMA-1Met (APR-246) and 5-azacitidine in TP53-mutated myelody-splastic syndromes and acute myeloid leukemia
    Maslah, Nabih
    Salomao, Norman
    Drevon, Louis
    Verger, Emmanuelle
    Partouche, Nicolas
    Ly, Pierre
    Aubin, Philippe
    Naoui, Nadia
    Schlageter, Marie-Helene
    Bally, Cecile
    Miekoutima, Elsa
    Rahme, Ramy
    Lehmann-Che, Jacqueline
    Ades, Lionel
    Fenaux, Pierre
    Cassinat, Bruno
    Giraudier, Stephane
    HAEMATOLOGICA, 2020, 105 (06) : 1539 - 1551
  • [29] APR-246 enhances tumor immunogenicity even in the absence of p53
    Venkatesh, Divya
    Michels, Judith
    Liu, Cailian
    Budhu, Sadna
    George, Mariam M.
    Abrahmsen, Lars
    Zappasodi, Roberta
    Wolchok, Jedd D.
    Merghoub, Taha
    CANCER RESEARCH, 2022, 82 (12)
  • [30] Impaired epithelial differentiation of induced pluripotent stem cells from Ectodermal Dysplasia EEC patients is rescued by APR-246/PRIMA-1MET
    Aberdam, Daniel
    Shalom-Feuerstein, Ruby
    Wiman, Klas
    van Bokhoven, Hans
    Petit, Isabelle
    HUMAN GENE THERAPY, 2012, 23 (10) : A40 - A41
12345